SA
VKTX logo
Viking Therapeutics, Inc.(VKTX)
Closing price · checked 8:43 PM ETAbout this dataData status
$24.77▼-1.07 (-4.14%)
Extended:$25.10+0.33 (+1.33%)· 8:43 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Viking Therapeutics, Inc. (VKTX)

Operating Expenses

$648.57M

TTM · Period ending: · USD

VKTX logo

VKTX Operating Expenses

Latest reported$648.57M
VKTX Operating Expenses ($438.56 → $648.57M)
High-resolution chart · PNG

What is operating expenses?

Expenses from normal business operations (SG&A, R&D, etc.).

VKTX operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Viking Therapeutics, Inc. Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)Change
393,342,000+160.63%
150,921,000+49.68%
100,827,000+43.31%
70,355,000+26.35%
55,682,000+30.52%
42,662,000+31.56%
32,427,000+23.95%
26,161,000+37.18%
19,070,189+37.72%
13,847,275+15.43%
11,996,478−48.88%
23,467,983+23,118.16%
101,076+22,947.04%
439—

Frequently asked questions: VKTX operating expenses

What is Viking Therapeutics, Inc. (VKTX)'s current operating expenses?

Viking Therapeutics, Inc. (VKTX)'s latest reported operating expenses (TTM) is $648.57M as of Sep 30, 2026. Expenses from normal business operations (SG&A, R&D, etc.).

How much historical operating expenses data is available for VKTX?

Stock Alarm Pro provides 14 dated annual fiscal periods observations for Viking Therapeutics, Inc. (VKTX)'s operating expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare VKTX's operating expenses to peers or set an alert?

You can open VKTX's operating expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on VKTX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.